Doximity Inc.: Beat — EPS $0.36, Revenue $174.54M
Earnings BeatQ2 2027 · After-market
Did Doximity Inc. (DOCS) beat earnings?
Yes, Doximity Inc. (DOCS) beat Wall Street analyst expectations for Q2 2027, reporting higher-than-expected EPS and higher-than-expected revenue.
Earnings Per Share+2.86% surprise
$0.36Actual
Expected: $0.35
vs. year ago -20.0%
Total Revenue+2.49% surprise
$174.54MActual
Expected: $170.3M
vs. year ago +4.0%
Released Nov 05 · 4:01 PM ET
Earning Report
| Metric | Q2 FY27 | Q2 FY26 | YoY Change % |
|---|---|---|---|
| Revenue | $174.54M | $168.53M | +4.0 |
| Net Income | $34.73M | $62.06M | -44.0 |
| GAAP Basic EPS | $0.19 | $0.33 | -42.4 |
| GAAP Diluted EPS | $0.18 | $0.31 | -41.9 |
| Non-GAAP Basic EPS | $0.38 | $0.48 | -20.8 |
| Non-GAAP Diluted EPS | $0.36 | $0.45 | -20.0 |
Financial Outlook / Guidance
| Metric | Q3 FY27 Outlook | FY27 Outlook |
|---|---|---|
| Guidance | Guidance | |
| Revenue | $195M-$196M | $678M-$683M |
| Adjusted EBITDA | $102.5M-$103.5M | $317M-$325M |
Q3 FY27 Outlook
- Revenue
- Guidance$195M-$196M
- Adjusted EBITDA
- Guidance$102.5M-$103.5M
FY27 Outlook
- Revenue
- Guidance$678M-$683M
- Adjusted EBITDA
- Guidance$317M-$325M
Business Highlights
- ➤Delivered record engagement while investing heavily in AI.
- ➤More than 190 health systems purchased Doximity’s AI suite.
- ➤Added UpToDate and DoseCheck to extend distribution and trust.
- ➤Repurchased $54.198M of common stock during the quarter.
- ➤Doximity’s network includes more than 85% of U.S. physicians.
- ➤Platform offers AI-powered clinical reference and search capabilities.
- ➤Workflow tools include Ask, PeerCheck, Amion, and Scribe.
Management Commentary
Jeff Tangney, co-founder and CEO of Doximity
“We delivered another quarter of record engagement while investing heavily in AI and maintaining a 51% adjusted EBITDA margin. More than 190 health systems have now purchased our AI suite, and with UpToDate and DoseCheck, we’re extending our lead in distribution and trust.”